Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06149130
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2023-11-20
Brief Title:
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HRHER2 - Advanced Breast Cancer
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Organization Data
Organization:
Tongji Hospital
Class:
OTHER
Study ID:
TJ-IRB20231105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tongji Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Huihua Xiong
Responsible Party Title:
Tongji Hospital Affiliated of Tongji Medical College Huazhong University of Science and Technology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tongji Hospital
Old Name:
None
Old Organization:
None